All In Biotech

Drug Trial Radar · NCT04667013

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

A Bridged Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TBN in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Sep 1, 2028

Primary completion

Mar 31, 2029

Study completion Aug 30, 2029

Sponsor

Sponsor type
Industry
First posted
Dec 14, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by the body) of TBN in healthy participants.

Conditions

  • Healthy

Interventions

  • Tetramethylpyrazine nitrone (TBN) tablet / PlaceboDrug

    Subjects will be administered multiple oral doses of TBN or matching placebo tablets twice a day for 6 consecutive days and a last dose in the morning of Day 7.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Adverse Events (AEs)Time frame: 14 days
  2. Assessment of physical examination.Time frame: 14 days
  3. Assessment of vital signs.Time frame: 14 days
  4. Assessment of 12 lead-ECG.Time frame: 14 days
  5. Assessment of urine pregnancy.Time frame: 14 days
  6. Assessment of Clinical Laboratory Tests.Time frame: 14 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.